<!DOCTYPE html><html><head><title> Pacifica Code Section 31A-22-S613.5 </title><link rel="stylesheet" href="../../../assets/style.css"/></head><body>
<b><i>
                      Effective 1/1/2020</i></b>
<br>
<b>31A-22-613.5.&nbsp;
          </b><b>Price and value comparisons of health insurance.</b>
<br>
<a id="31A-22-613.5(1)" name="31A-22-613.5(1)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(1)</td><td style="width:99%"><a id="31A-22-613.5(1)(a)" name="31A-22-613.5(1)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
This section applies to all health benefit plans.</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(1)(b)" name="31A-22-613.5(1)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
Subsection <a href="#31A-22-613.5(2)">(2)</a> applies to:<a id="31A-22-613.5(1)(b)(i)" name="31A-22-613.5(1)(b)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
all health benefit plans; and</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(1)(b)(ii)" name="31A-22-613.5(1)(b)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
coverage offered to state employees under Subsection <a href="../../Title49/Chapter20/49-20-S202.html?v=C49-20-S202_1800010118000101#49-20-202(1)(a)">49-20-202(1)(a)</a>.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(2)" name="31A-22-613.5(2)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(2)</td><td style="width:99%">
The commissioner shall promote informed consumer behavior and responsible health benefit plans by requiring an insurer issuing a health benefit plan to provide to all enrollees, before enrollment in the health benefit plan, written disclosure of:
<a id="31A-22-613.5(2)(a)" name="31A-22-613.5(2)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
restrictions or limitations on prescription drugs and biologics, including:<a id="31A-22-613.5(2)(a)(i)" name="31A-22-613.5(2)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
the use of a formulary;</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(2)(a)(ii)" name="31A-22-613.5(2)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
co-payments and deductibles for prescription drugs; and</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(2)(a)(iii)" name="31A-22-613.5(2)(a)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
requirements for generic substitution;</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(2)(b)" name="31A-22-613.5(2)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
coverage limits under the plan;</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(2)(c)" name="31A-22-613.5(2)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
any limitation or exclusion of coverage, including:<a id="31A-22-613.5(2)(c)(i)" name="31A-22-613.5(2)(c)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
a limitation or exclusion for a secondary medical condition related to a limitation or exclusion from coverage; and</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(2)(c)(ii)" name="31A-22-613.5(2)(c)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
easily understood examples of a limitation or exclusion of coverage for a secondary medical condition;</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(2)(d)" name="31A-22-613.5(2)(d)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(d)</td><td style="width:99%"><a id="31A-22-613.5(2)(d)(i)" name="31A-22-613.5(2)(d)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%"><a id="31A-22-613.5(2)(d)(i)(A)" name="31A-22-613.5(2)(d)(i)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
each drug, device, and covered service that is subject to a preauthorization requirement as defined in Section <a href="../../Title31A/Chapter22/31A-22-S650.html?v=C31A-22-S650_2019051420200101">31A-22-650</a>; or</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(2)(d)(i)(B)" name="31A-22-613.5(2)(d)(i)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
if listing each device or covered service in accordance with Subsection <a href="#31A-22-613.5(2)(d)(i)(A)">(2)(d)(i)(A)</a> is too numerous to list separately, all devices or covered services in a particular category where all devices or covered services have the same preauthorization requirement;</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(2)(d)(ii)" name="31A-22-613.5(2)(d)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
each requirement for authorization as defined in Section <a href="../../Title31A/Chapter22/31A-22-S650.html?v=C31A-22-S650_2019051420200101">31A-22-650</a> for:
<a id="31A-22-613.5(2)(d)(ii)(A)" name="31A-22-613.5(2)(d)(ii)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
each drug, device, or covered service described in Subsection <a href="#31A-22-613.5(2)(d)(i)(A)">(2)(d)(i)(A)</a>; and</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(2)(d)(ii)(B)" name="31A-22-613.5(2)(d)(ii)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
each category of devices or covered services described in Subsection <a href="#31A-22-613.5(2)(d)(i)(B)">(2)(d)(i)(B)</a>; and</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(2)(d)(iii)" name="31A-22-613.5(2)(d)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
sufficient information to allow a network provider or enrollee to submit all of the information to the insurer necessary to meet each requirement for authorization described in Subsection <a href="#31A-22-613.5(2)(d)(ii)">(2)(d)(ii)</a>;</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(2)(e)" name="31A-22-613.5(2)(e)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(e)</td><td style="width:99%">
whether the insurer permits an exchange of the adoption indemnity benefit in Section <a href="../../Title31A/Chapter22/31A-22-S610.1.html?v=C31A-22-S610.1_2017050920180101">31A-22-610.1</a> for infertility treatments, in accordance with Subsection <a href="../../Title31A/Chapter22/31A-22-S610.1.html?v=C31A-22-S610.1_2017050920180101#31A-22-610.1(1)(c)(ii)">31A-22-610.1(1)(c)(ii)</a> and the terms associated with the exchange of benefits; and</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(2)(f)" name="31A-22-613.5(2)(f)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(f)</td><td style="width:99%">
whether the insurer provides coverage for telehealth services in accordance with Section <a href="../../Title26/Chapter18/26-18-S13.5.html?v=C26-18-S13.5_2019051420190514">26-18-13.5</a> and terms associated with that coverage.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(3)" name="31A-22-613.5(3)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(3)</td><td style="width:99%">
An insurer shall provide the disclosure required by Subsection <a href="#31A-22-613.5(2)">(2)</a> in writing to the commissioner:
<a id="31A-22-613.5(3)(a)" name="31A-22-613.5(3)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
upon commencement of operations in the state; and</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(3)(b)" name="31A-22-613.5(3)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
anytime the insurer amends any of the following described in Subsection <a href="#31A-22-613.5(2)">(2)</a>:<a id="31A-22-613.5(3)(b)(i)" name="31A-22-613.5(3)(b)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
treatment policies;</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(3)(b)(ii)" name="31A-22-613.5(3)(b)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
practice standards;</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(3)(b)(iii)" name="31A-22-613.5(3)(b)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
restrictions;</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(3)(b)(iv)" name="31A-22-613.5(3)(b)(iv)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iv)</td><td style="width:99%">
coverage limits of the insurer's health benefit plan or health insurance policy; or</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(3)(b)(v)" name="31A-22-613.5(3)(b)(v)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(v)</td><td style="width:99%">
limitations or exclusions of coverage including a limitation or exclusion for a secondary medical condition related to a limitation or exclusion of the insurer's health insurance plan.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(4)" name="31A-22-613.5(4)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(4)</td><td style="width:99%"><a id="31A-22-613.5(4)(a)" name="31A-22-613.5(4)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
An insurer shall provide the enrollee with notice of an increase in costs for prescription drug coverage due to a change in benefit design under Subsection <a href="#31A-22-613.5(2)(a)">(2)(a)</a>:<a id="31A-22-613.5(4)(a)(i)" name="31A-22-613.5(4)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
either:
<a id="31A-22-613.5(4)(a)(i)(A)" name="31A-22-613.5(4)(a)(i)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
in writing; or</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(4)(a)(i)(B)" name="31A-22-613.5(4)(a)(i)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
on the insurer's website; and</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(4)(a)(ii)" name="31A-22-613.5(4)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
at least 30 days prior to the date of the implementation of the increase in cost, or as soon as reasonably possible.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(4)(b)" name="31A-22-613.5(4)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
If under Subsection <a href="#31A-22-613.5(2)(a)">(2)(a)</a> a formulary is used, the insurer shall make available to prospective enrollees and maintain evidence of the fact of the disclosure of:<a id="31A-22-613.5(4)(b)(i)" name="31A-22-613.5(4)(b)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
the drugs included;</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(4)(b)(ii)" name="31A-22-613.5(4)(b)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
the patented drugs not included;</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(4)(b)(iii)" name="31A-22-613.5(4)(b)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
any conditions that exist as a precedent to coverage; and</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(4)(b)(iv)" name="31A-22-613.5(4)(b)(iv)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iv)</td><td style="width:99%">
any exclusion from coverage for secondary medical conditions that may result from the use of an excluded drug.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(4)(c)" name="31A-22-613.5(4)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
The commissioner shall develop examples of limitations or exclusions of a secondary medical condition that an insurer may use under Subsection <a href="#31A-22-613.5(2)(c)">(2)(c)</a>.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(5)" name="31A-22-613.5(5)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(5)</td><td style="width:99%">
Examples of a limitation or exclusion of coverage provided under this section or otherwise are for illustrative purposes only, and the failure of a particular fact situation to fall within the description of an example does not, by itself, support a finding of coverage.</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(6)" name="31A-22-613.5(6)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(6)</td><td style="width:99%">
An insurer shall:
<a id="31A-22-613.5(6)(a)" name="31A-22-613.5(6)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
post the information described in Subsection <a href="#31A-22-613.5(2)(d)">(2)(d)</a> on the insurer's website and provider portal;</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(6)(b)" name="31A-22-613.5(6)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
if requested by an enrollee, provide the enrollee with the information required by this section by mail or email; and</td>
</tr>
</tbody></table>
<a id="31A-22-613.5(6)(c)" name="31A-22-613.5(6)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
if requested by a network provider for a specific drug, device, or covered service, provide the network provider with the information described in Subsection <a href="#31A-22-613.5(2)(d)">(2)(d)</a> for the drug, device, or covered service by mail or email.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<br>
<br>Amended by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=439&amp;sess=2019GS">439</a>, 2019 General Session<br>
</body></html>